Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Treatment of Major Depressive Disorder (MDD) in Adults
.
Show all posts
Showing posts with label
Treatment of Major Depressive Disorder (MDD) in Adults
.
Show all posts
Monday, February 16, 2026
FDA Approves Caplyta (lumateperone) as an Adjunctive Therapy for the Treatment of Major Depressive Disorder (MDD) in Adults
›
In continuation of my update on lumateperone Johnson & Johnson (NYSE: JNJ) announced the U.S. Food and Drug Administration (FDA) approva...
›
Home
View web version